A phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585 - Trial in progress Meeting Abstract
| Authors: | Bang, Y.; Van Cutsem, E.; Fuchs, C.; Ohtsu, A.; Tabernero, J.; Ilson, D.; Hyung, W.; Strong, V.; Goetze, T.; Yoshikawa, T.; Tang, L.; Hwang, P.; Shitara, K. |
| Abstract Title: | A phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585 - Trial in progress |
| Meeting Title: | ESMO 20th World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2018 Jun 20-23 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-06-01 |
| Start Page: | mdy151.095 |
| Language: | English |
| ACCESSION: | WOS:000439970900140 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy151.095 |
| Notes: | Meeting Abstract: P-096 -- Appears on page v26 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work